Search research articles
Contact Us
Filters
Showing results (1-10 of 11) with videos related to
Page
of 2
Sort By:
Annals of Hepatology
|
May 13, 2019
Comparing drug interaction frequencies of various hepatitis C treatment regimens among monoinfected patients
Alisha Ahmed, Christopher Schriever, Nicholas Britt, et al.
AIDS Patient Care and Stds
|
August 4, 2017
Relationship Between Single Tablet Antiretroviral Regimen and Adherence to Antiretroviral and Non-Antiretroviral Medications Among Veterans' Affairs Patients with Human Immunodeficiency Virus
Jenna Yager, John Faragon, Liam McGuey, et al.
Lancet (London, England)
|
March 14, 2025
Pharmacokinetics and safety of once-yearly lenacapavir: a phase 1, open-label study
Vamshi Jogiraju, Pallavi Pawar, Jenna Yager, et al.
AIDS Research and Human Retroviruses
|
August 9, 2022
Pharmacokinetics of Emtricitabine/Tenofovir Disoproxil Fumarate Among Transgender Adolescents and Young Adults Without HIV Receiving Gender Affirming Hormones
Jenna Yager, Kristina M Brooks, Jennifer Brothers, et al.
AIDS Research and Human Retroviruses
|
November 16, 2020
Individualized Adherence Benchmarks for HIV Pre-Exposure Prophylaxis
Mustafa E Ibrahim, Jose R Castillo-Mancilla, Jenna Yager, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 9, 2020
Sex Hormone Therapy and Tenofovir Diphosphate Concentration in Dried Blood Spots: Primary Results of the Interactions Between Antiretrovirals And Transgender Hormones Study
Robert M Grant, Marion Pellegrini, Patricia A Defechereux, et al.
AIDS Research and Human Retroviruses
|
July 11, 2022
Gender-Affirming Hormone Pharmacokinetics Among Adolescent and Young Adult Transgender Persons Receiving Daily Emtricitabine/Tenofovir Disoproxil Fumarate
Jenna Yager, Kristina M Brooks, Jennifer Brothers, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
June 17, 2020
Intracellular Tenofovir-Diphosphate and Emtricitabine-Triphosphate in Dried Blood Spots Following Tenofovir Alafenamide: The TAF-DBS Study
Jenna Yager, Jose Castillo-Mancilla, Mustafa E Ibrahim, et al.
Transgender Health
|
February 5, 2024
Gender Affirming Hormones Do Not Affect the Exposure and Efficacy of F/TDF or F/TAF for HIV Preexposure Prophylaxis: A Subgroup Analysis from the DISCOVER Trial
Michelle S Cespedes, Moupali Das, Jenna Yager, et al.
Open Forum Infectious Diseases
|
July 21, 2021
Lower Urine Tenofovir Concentrations Among Individuals Taking Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate: Implications for Point-of-Care Testing
Kelly A Johnson, Xin Niu, David V Glidden, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 11) with videos related to
Sort By:
Page
of 2
Annals of Hepatology
|
May 13, 2019
Comparing drug interaction frequencies of various hepatitis C treatment regimens among monoinfected patients
Alisha Ahmed, Christopher Schriever, Nicholas Britt, et al.
AIDS Patient Care and Stds
|
August 4, 2017
Relationship Between Single Tablet Antiretroviral Regimen and Adherence to Antiretroviral and Non-Antiretroviral Medications Among Veterans' Affairs Patients with Human Immunodeficiency Virus
Jenna Yager, John Faragon, Liam McGuey, et al.
Lancet (London, England)
|
March 14, 2025
Pharmacokinetics and safety of once-yearly lenacapavir: a phase 1, open-label study
Vamshi Jogiraju, Pallavi Pawar, Jenna Yager, et al.
AIDS Research and Human Retroviruses
|
August 9, 2022
Pharmacokinetics of Emtricitabine/Tenofovir Disoproxil Fumarate Among Transgender Adolescents and Young Adults Without HIV Receiving Gender Affirming Hormones
Jenna Yager, Kristina M Brooks, Jennifer Brothers, et al.
AIDS Research and Human Retroviruses
|
November 16, 2020
Individualized Adherence Benchmarks for HIV Pre-Exposure Prophylaxis
Mustafa E Ibrahim, Jose R Castillo-Mancilla, Jenna Yager, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America
|
August 9, 2020
Sex Hormone Therapy and Tenofovir Diphosphate Concentration in Dried Blood Spots: Primary Results of the Interactions Between Antiretrovirals And Transgender Hormones Study
Robert M Grant, Marion Pellegrini, Patricia A Defechereux, et al.
AIDS Research and Human Retroviruses
|
July 11, 2022
Gender-Affirming Hormone Pharmacokinetics Among Adolescent and Young Adult Transgender Persons Receiving Daily Emtricitabine/Tenofovir Disoproxil Fumarate
Jenna Yager, Kristina M Brooks, Jennifer Brothers, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)
|
June 17, 2020
Intracellular Tenofovir-Diphosphate and Emtricitabine-Triphosphate in Dried Blood Spots Following Tenofovir Alafenamide: The TAF-DBS Study
Jenna Yager, Jose Castillo-Mancilla, Mustafa E Ibrahim, et al.
Transgender Health
|
February 5, 2024
Gender Affirming Hormones Do Not Affect the Exposure and Efficacy of F/TDF or F/TAF for HIV Preexposure Prophylaxis: A Subgroup Analysis from the DISCOVER Trial
Michelle S Cespedes, Moupali Das, Jenna Yager, et al.
Open Forum Infectious Diseases
|
July 21, 2021
Lower Urine Tenofovir Concentrations Among Individuals Taking Tenofovir Alafenamide Versus Tenofovir Disoproxil Fumarate: Implications for Point-of-Care Testing
Kelly A Johnson, Xin Niu, David V Glidden, et al.
Page
of 2